Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mahsa Babaei has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Abu Sikder

    Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, United States

    1 shared publication
  • Albert F. Yang

    Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA

    1 shared publication
  • Alexis Deavenport-Saman

    Division of General Pediatrics, Children's Hospital Los Angeles, Los Angeles CA; Department of Pediatrics, University of Southern California Keck School of Medicine, USA

    1 shared publication
  • Bradley S. Peterson

    Department of Pediatrics, Division of Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles Los Angeles California USA

    1 shared publication
  • Choo Phei Wee

    Southern California Clinical and Translational Science Institute, Los Angeles, CA, United States

    1 shared publication
  • Christopher J. Machle

    Department of Pediatrics, Division of Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles Los Angeles California USA

    1 shared publication

Latest Publications

  • Open Access

    Personal Activity Trackers and Family Engagement in a Pediatric Obesity Intervention: Randomized Controlled Trial

    by Juan Carlos Espinoza Salomon, Mahsa Babaei, Alexis Deavenport-Saman, Olga Solomon, Choo Phei Wee, Ramon Durazo-Arvizu, Abu Sikder, Payal Shah, Patricia Castillo, Larry Yin

    Background: Pediatric obesity continues to be a national health crisis. Parents play a critical role in obesity interventions. Digital health interventions, such as personal activity trackers, can help better engage parents in pediatric obesity interventions and improve outcomes. Objective: This study aimed to (1) assess the feasibility and acceptability of implementing personal activity trackers as part of a comprehensive family-based lifestyle intervention for pediatric obesity (BodyWorks) in a Federally Qualified Health Center; (2) evaluate the impact of personal activity trackers on parents’ engagement, participant anthropometrics, and the overall program; and (3) examine the associations between steps per day and usage (minutes) with body composition outcomes. Methods: A total of 158 families were randomized to the control (BodyWorks) or intervention (BodyWorks + physical activity tracker) arm. Mean levels of weight-by-height outcomes, including BMI, BMI z scores, and BMI percent of the 95th percentile, were compared between the 2 groups. Results: There were no differences between study arms at baseline. After adjustment, there was a significant group difference in children’s BMI z scores from baseline to the postintervention time point ( P for interaction=.01). Conclusions: Families in the intervention group that completed the program had slightly better weight outcomes than the controls. Engaging parents through digital health interventions may be an effective way to enhance existing pediatric obesity intervention programs.


  • Open Access

    Perioperative Methadone in Orthopedic Surgery: A Scoping Review

    by Albert F. Yang, Emily Lee, Mahsa Babaei, Paul Lee

    Background/Objective: The present study is a scoping review of the literature from Medline, PubMed, and Scopus databases from 2000 to 2025. Studies were selected based on predefined criteria, including the intraoperative administration of methadone during orthopedic surgery and the reporting of outcomes such as pain scores, opioid consumption, or adverse effects. A qualitative synthesis of the findings from 13 selected studies was performed to evaluate the existing literature on the efficacy and safety of perioperative methadone for postoperative pain management in orthopedic surgery. Methods: Studies were selected based on predefined criteria, including the intraoperative administration of methadone during orthopedic surgery and the reporting of outcomes such as pain scores, opioid consumption, or adverse effects. A qualitative synthesis of the findings from 13 selected studies was performed. Results: Randomized controlled trials in adult spine surgery consistently showed that intraoperative methadone (0.2 mg/kg) significantly reduced postoperative opioid consumption by up to 50% and lowered pain scores for up to 72 h compared to other opioids. Similar benefits were observed in pediatric spine surgery, particularly with multimodal regimens including methadone, which reduced total opioid use by as much as 76%. However, for arthroscopic knee surgery, morphine provided superior analgesia compared to methadone. The safety profile of perioperative methadone appears acceptable, with no major adverse events reported when dosed appropriately. Conclusions: Perioperative methadone is an effective analgesic adjunct that reduces postoperative pain and opioid requirements, especially in major spine surgery when integrated into a multimodal strategy. Its efficacy varies by surgical context, and further high-quality research is needed to define optimal dosing and its role in other orthopedic procedures.


  • Pre‐pregnancy maternal obesity and infant neurodevelopmental outcomes in Latino infants

    by Mahsa Babaei, Christopher J. Machle, Pari Mokhtari, Jonatan Ottino González, Kelsey A. Schmidt, Tanya L. Alderete, Shana Adise, Bradley S. Peterson, Michael I. Goran

    Objective: This study explores the impact of maternal pre‐pregnancy BMI on infant neurodevelopment at 24 months in low‐income Latino families. It also investigates whether infant diet mediates this relationship.Methods: Latino mother‐infant pairs (n = 163) were enrolled at 1 month post partum and were followed for 2 years, with assessments at 6‐month intervals. Maternal pre‐pregnancy anthropometrics were self‐reported at baseline, and child neurodevelopment was assessed at 24 months using the Bayley Scales of Infant Development. Diet quality of infants was measured using the Healthy Eating Index (HEI)‐2015 and HEI‐Toddlers‐2020 scores at multiple time points. Mediation and regression models that adjust for maternal factors were used to examine the associations.Results: Pre‐pregnancy BMI showed significant negative associations with child cognitive scores (β = −0.1, 95% CI: −0.2 to −0.06, p < 0.001) and language scores (β = −0.1, 95% CI: −0.2 to −0.03, p = 0.01) at 24 months. Infant HEI‐2015 scores at 24 months partly mediated these associations, explaining 23% and 30% of the total effect on cognitive and language subscales, respectively. No specific dietary components in infants mediated the relationship, except for the total HEI‐2015 score.Conclusions: Managing maternal obesity pre‐pregnancy is crucial for improving infant neurodevelopmental outcomes, especially in low‐income Latino families. Promoting healthy weight and enhancing infant diet quality can enhance neurodevelopment in these populations.


  • Open Access

    Supplemental Nutrition Assistance Program (SNAP): does receiving assistance impact food choices?

    by Prageet K Sachdev, Mahsa Babaei, Jeanne H Freeland-Graves

    The Supplemental Nutrition Assistance Program (SNAP) is the largest federal program that provides assistance for the purchase of foods to low-income households in the United States. SNAP plays a valuable role in alleviating hunger and food insecurity in poor households; however, one consideration that remains relatively unexplored is the influence of this program on food choices. Food choices are guided by several factors in low-income individuals, including the cost of food, household size, nutrition knowledge, availability of fresh foods in the neighborhood, transportation, and cultural factors. Also, the complex relationship between SNAP participation and food choices is further confounded by the factors of demographics, food insecurity, poverty, and self-selection. There is a lack of quantitative investigations that directly evaluate food choices in SNAP recipients. As a result, this review will focus on summarizing finding from studies that assessed food purchasing patterns, diet quality, and weight gain in SNAP participants. These outcomes may serve as proxy measures to evaluate the food choices made by SNAP participants. In addition, this review discusses many behavioral economic strategies such as reducing the cost of healthy foods, providing monetary benefits for purchase of healthy foods, increasing the SNAP benefits, incentivizing small food retailers to offer more food choices in low-income neighborhoods, increasing grocery stores and supermarkets in poor neighborhood, and strengthening the SNAP-Ed program; some of which have been previously adopted to promote the selection of healthy foods in SNAP participants. SNAP has the potential to impact food choices in the society, as such longitudinal studies are needed to evaluate the effectiveness of any reforms in SNAP benefits or restrictions, which may seem logical but not impact food choices in reality.


  • Quantifying the association between acute leukemia and serum zinc, copper, and selenium: a meta-analysis

    by Sangyoung Kim, Jeanne H. Freeland-Graves, Mahsa Babaei, Prageet K. Sachdev, S. Natasha Beretvas

    Acute leukemia is a clonal malignant disorder that occurs when immature blast cells accumulate in bone marrow. Zinc (Zn) and copper (Cu) are related to normal lymphocyte maturation and immune function regulation. Selenium (Se) is protective against oxidative damage. The aim of this meta-analysis is to statistically synthesize results from studies that have investigated the levels of Zn, Cu, and Se in acute leukemia patients. The effect size, delta, was used to standardize the raw data. The robust variance estimation (RVE) method was performed to measure the pooled effect size and variance. Results suggest significant negative differences for levels of serum Zn (p < .05, delta = −1.21; 95% CI, −2.13-−0.28) and Se (p < .05, delta = −1.84; 95% CI, −3.39-−0.29) and significantly positive differences between serum Cu levels (p < .01, delta = 1.94; 95% CI, 1.02–2.87) in acute leukemia, as compared to the controls.